NIVF vs ATPC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

NIVF

41.3
AI Score
VS
NIVF Wins

ATPC

38.0
AI Score

Investment Advisor Scores

NIVF

41score
Recommendation
HOLD

ATPC

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF ATPC Winner
Forward P/E 0.0071 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 11.9% -93.4% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 41.3/100 38.0/100 NIVF
Profit Margin 209.0% -86.3% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY NIVF

Relative Price Performance (Last 90 Days)

NIVF 1M: -92.4% · 3M: -78.1% ATPC 1M: -14.4% · 3M: -28.6%

Current Technical Phase

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.1%), weak momentum, RSI 30

RSI (14): 29.6 · Price: $0.10

ATPC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.6%), weak momentum, RSI 29

RSI (14): 28.5 · Price: $2.02

Fundamentals Snapshot

Metric NIVF ATPC
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.1% -0.9%
Gross Margin 0.2% 0.6%
Operating Margin -3.5% -40.2%
EPS 144.94 -0.96
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.